Mebeverine HCl SR Pellets

Product Overview

Mebeverine Hydrochloride SR Pellets are designed to deliver sustained therapeutic effects by gradually releasing Mebeverine HCl over a 12–24 hour period. Mebeverine is a smooth muscle relaxant commonly used for the treatment of Irritable Bowel Syndrome (IBS) and other gastrointestinal spasmodic conditions. These pellets utilize advanced polymer-coating technologies to ensure controlled drug release, maintaining stable plasma concentrations and improving patient adherence.

Product Name
Mebeverine HCl SR Pellets
Strengths Available
50% - 80%
CAS No. / IUPAC Name
CAS: 13571-98-1; IUPAC: 2-(Diphenylmethoxy)-N,N-dimethylethanamine hydrochloride
Molecular Formula / Weight
C19H23NO · HCl / ~303.86 g/mol
Identification
Validated HPLC Method (USP/BP/EP compliant)
Release Type
Sustained Release (SR) – polymer-coated pellets for controlled release over 12–24 hours
Applications
Oral extended-release formulations such as capsules or sachets, targeting relief from abdominal pain and spasms associated with IBS
Storage Conditions
Store in a well-closed container in a cool, dry place, protected from light and moisture

Acetaminophen DC Granules – Typical Composition

Component	Function
Mebeverine Hydrochloride	Active Pharmaceutical Ingredient (API)
Sugar Spheres / MCC Spheres	Inert core / Neutral starter spheres
Hydroxypropyl Methylcellulose (HPMC) / Povidone (PVP)	Binder / Film former for drug layering
Ethyl Cellulose / Eudragit RS	Sustained-release polymer coating for controlled release
PEG 6000 / Triethyl Citrate	Plasticizer to enhance coating flexibility
Talc / Colloidal Silicon Dioxide	Anti-adherent / Glidant
Purified Water	Solvent (evaporated during processing)

Why Choose Pellets from Salius Pharma?

Salius Pharma offers Mebeverine HCl SR Pellets manufactured in USFDA-approved, WHO-GMP, and ISO-certified facilities in India, ensuring adherence to the highest global quality and regulatory standards. Our pellets are formulated using advanced layering and solubilization technologies to enhance bioavailability and provide consistent immediate release. Available in customizable strengths and pellet sizes, these.

Key Advantages of Partnering with Salius Pharma

Cost-Efficient Setup
Avoid heavy capital investment in infrastructure and workforce.
Guaranteed Quality Assurance
Products are sourced only from certified facilities with validated processes.
Access to Advanced Technology
Benefit from the latest drug delivery systems without managing the tech in-house.
Accelerated Market Entry
Launch products faster and establish your brand in less time.
Custom Formulation Support
Flexibility to offer tailored pellet solutions as per your market needs.

Expected Delivery Time

We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.

Place an Order or Request a Quote from Salius Pharma

Looking to source Mebeverine HCl SR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.

Get in Touch

Email: export@saliuspharma.com
Call / WhatsApp: +91 84258 80640 / +91 84258 80643
Landline: +91 22 49700 601 / +91 22 44503 148
Corporate Office: 3104–3106, Plan S Business Park, Nerul MIDC Opp. Dr. D.Y. Patil Stadium, Navi Mumbai – 400706, Maharashtra, India

Confidentiality Notice

The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.

Any patented products are excluded from our offerings in regions where such patents are currently in force.

FAQs

Mebeverine HCl SR Pellets are engineered to release the active drug gradually over a period of 12–24 hours. This controlled release allows for once- or twice-daily dosing, improving formulation flexibility and patient compliance in gastrointestinal therapies.

Yes, Salius Pharma offers customized drug loadings, typically ranging from 30% to 80%, based on client requirements. This enables precise formulation development for various capsule or sachet dosage forms.

The pellets use pharmaceutically approved polymers such as ethyl cellulose or HPMC for sustained release, along with inert cores and functional excipients that ensure uniformity, stability, and regulatory compliance.

We offer bulk packaging in double-lined HDPE containers or aluminum-lined fiber drums, sealed to protect against moisture and light. Packaging complies with international shipping and storage standards for raw pharmaceutical materials.

Enquiry